Taveras Arthur 4
4 · X4 Pharmaceuticals, Inc · Filed Dec 1, 2020
Insider Transaction Report
Form 4
Taveras Arthur
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2020-11-30$6.60/sh+121,150$799,590→ 121,150 totalExercise: $6.60Exp: 2030-11-29→ Common Stock (121,150 underlying)
Footnotes (1)
- [F1]25% of the shares subject tot he option shall vest on November 30, 2021, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.